We are live on
!
Find out more
GC
Gratus Capital Portfolio holdings
AUM
$2.5B
1-Year Est. Return
32.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.1%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
–
AUM
$680M
AUM Growth
+$224M
(+49%)
Cap. Flow
+$222M
Cap. Flow
% of AUM
32.67%
Top 10 Holdings %
Top 10 Hldgs %
44.16%
Holding
182
New
111
Increased
38
Reduced
20
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAL
Valspar
VAL
|
+$8.08M |
| 2 |
Danaher
DHR
|
+$7.52M |
| 3 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$6.44M |
| 4 |
Graco
GGG
|
+$6.38M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$6.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$6.37M |
| 2 |
Medtronic
MDT
|
+$2.22M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$2.08M |
| 4 |
DuPont de Nemours
DD
|
+$2.06M |
| 5 |
Invesco Large Cap Value ETF
PWV
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 34.55% |
| 2 | Financials | 10.83% |
| 3 | Healthcare | 10.25% |
| 4 | Industrials | 9.41% |
| 5 | Technology | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
101
Novo Nordisk
NVO
$216B
| $1.12M | 0.17% |
+41,772
| New | +$1.15M |
|
|
SNV
102
DELISTED
Synovus
SNV
| $1.11M | 0.16% |
+38,150
| New | +$1.16M |
|
103
John Wiley & Sons Class A
WLY
$2.52B
| $1.09M | 0.16% |
+20,834
| New | +$1.05M |
|
104
Altria Group
MO
$122B
| $1.06M | 0.16% |
15,338
+3,731
| +32% | +$239K |
|
|
TSS
105
DELISTED
Total System Services, Inc.
TSS
| $1.06M | 0.16% |
+19,915
| New | +$1.03M |
|
106
M&T Bank
MTB
$36.2B
| $1.02M | 0.15% |
+8,620
| New | +$1M |
|
107
Northrop Grumman
NOC
$77B
| $1M | 0.15% |
+4,498
| New | +$947K |
|
|
EMC
108
DELISTED
EMC CORPORATION
EMC
| $969K | 0.14% |
+35,677
| New | +$964K |
|
109
Hershey
HSY
$35.4B
| $922K | 0.14% |
+8,123
| New | +$760K |
|
110
Wheaton Precious Metals
WPM
$50.6B
| $922K | 0.14% |
+39,200
| New | +$756K |
|
|
CLNY
111
DELISTED
Colony Capital, Inc.
CLNY
| $918K | 0.13% |
+59,828
| New | +$1.04M |
|
112
Reading International Class A
RDI
$32.9M
| $914K | 0.13% |
+73,185
| New | +$925K |
|
113
Verisk Analytics
VRSK
$26.4B
| $865K | 0.13% |
+10,671
| New | +$837K |
|
114
Walt Disney
DIS
$165B
| $856K | 0.13% |
8,750
+6,678
| +322% | +$668K |
|
115
Corning
GLW
$126B
| $820K | 0.12% |
+40,059
| New | +$803K |
|
|
FCE.A
116
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $783K | 0.12% |
+35,104
| New | +$765K |
|
117
Truist Financial
TFC
$63.2B
| $781K | 0.11% |
+21,946
| New | +$767K |
|
118
UGI
UGI
$8B
| $781K | 0.11% |
17,250
+1,200
| +7% | +$50.6K |
|
119
Polaris
PII
$4.15B
| $719K | 0.11% |
+8,800
| New | +$780K |
|
120
ConocoPhillips
COP
$147B
| $711K | 0.1% |
+16,310
| New | +$719K |
|
121
Vanguard Real Estate ETF
VNQ
$39.9B
| $683K | 0.1% |
7,705
+35
| +0.5% | +$2.94K |
|
122
Lesaka Technologies
LSAK
$388M
| $658K | 0.1% |
+65,823
| New | +$700K |
|
123
SK Telecom
SKM
$13.7B
| $654K | 0.1% |
+18,977
| New | +$626K |
|
124
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
| $643K | 0.09% |
8,002
+1,712
| +27% | +$136K |
|
125
Aflac
AFL
$63.9B
| $608K | 0.09% |
+16,864
| New | +$576K |
|
Similar funds
LFDLE
CDH
AT
BPCA
HIG
H
PRIG
PO
Gratus Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Gratus Capital held 182 positions worth $680M, up 49% from $456M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Gratus Capital deployed $222M of net new capital in Q2 2016, opening 111 new positions and adding to 38 existing holdings. Its largest new stake was Valspar: 75,300 shares worth $8.13M.
By sector, the portfolio is most concentrated in Consumer Staples at 35% of assets, down from 47% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $2.22M trimmed.
- Gratus Capital's largest Q2 2016 buy was Valspar: 75,300 shares worth $8.13M.
- Gratus Capital added most to Berkshire Hathaway Class B in Q2 2016, an estimated $6.38M increase.
- Gratus Capital's biggest Q2 2016 reduction was Medtronic, cutting an estimated $2.22M.
- Gratus Capital fully exited AbbVie in Q2 2016, selling an estimated $6.37M.
- Gratus Capital's ten largest holdings make up 44% of its $680M portfolio in Q2 2016.
- Gratus Capital opened 111 new positions and closed 5 in Q2 2016.
- Gratus Capital's portfolio value rose 49% quarter-over-quarter to $680M.
Based on Gratus Capital's 13F filing for Q2 2016, filed 3 Aug 2016.